HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk


New, Multicenter Trial of MB-106 Doses First Patient

Interim data from an ongoing study demonstrate continuing efficacy in B-NHL, CLL, and FL.

Around the Helix: Cell and Gene Therapy Company Updates – October 5, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

B-NHL Cell Therapy Cleared for Trials

Oncternal will soon initiate a phase 1/2 dose-escalation study of ONCT-808.